Effect of alirocumab on coronary plaque in patients with coronary artery disease assessed by optical coherence tomography

Abstract Background Proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors have been demonstrated to produce significantly greater reduction in LDL cholesterol levels and cardiovascular events than standard statin therapy. However, evidence on the impact of PCSK9 inhibitors on coronary pla...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Lipids in Health and Disease
المؤلفون الرئيسيون: Fei Gao, Zhi Jian Wang, Xiao Teng Ma, Hua Shen, Li Xia Yang, Yu Jie Zhou
التنسيق: مقال
اللغة:الإنجليزية
منشور في: BMC 2021-09-01
الموضوعات:
Coronary artery disease
PCSK9 inhibitors
Statins
Coronary plaque
Optical coherence tomography
الوصول للمادة أونلاين:https://doi.org/10.1186/s12944-021-01528-3

الانترنت

https://doi.org/10.1186/s12944-021-01528-3

مواد مشابهة